Di Felice Mariana, Rolfi Lucrezia Romana, Toso Julian, Pennacchietti Valeria, Ventura Eduarda S, Toto Angelo, Tramutola Antonella, Gianni Stefano
Dipartimento di Scienze Biochimiche "A. Rossi Fanelli", Sapienza Università di Roma, P.le Aldo Moro 5, Rome, 00185, Italy.
Laboratory affiliated to Istituto Pasteur Italia - Fondazione Cenci Bolognetti, Rome, Italy.
Biol Direct. 2025 May 23;20(1):63. doi: 10.1186/s13062-025-00656-5.
Adaptor proteins play a crucial role in signal transduction by facilitating the assembly of protein complexes at specific subcellular domains. These multifunctional molecules contain multiple binding modules that enhance the efficiency and flexibility of cellular signaling pathways, thereby orchestrating complex responses. Among these proteins, Grb2 (growth factor receptor-bound protein 2) emerges as a key regulator owing to its unique "sandwich" structure. Despite lacking intrinsic enzymatic activity, recent investigations have revealed that Grb2 acts not merely as a passive bridge but also utilizes intramolecular allosteric communication to modulate binding specificity. In this study, we compared the kinetic binding properties of SH2-SH3 belonging to Grb2 with Gab2 and the same experiment with bound states of the SH2 domain using two different peptides that mimics the physiological ligands of SH2. Our results demonstrate that the SH2 domain plays a critical regulatory role, exhibiting remarkably distinct behaviors in free and bound states, and depending on the ligand it binds to. This suggests how selectivity can be modulated by intradomain allostery. In vitro functional assays measuring the activation levels of the target protein further supported our hypothesis.
衔接蛋白通过促进特定亚细胞结构域处蛋白质复合物的组装,在信号转导中发挥关键作用。这些多功能分子包含多个结合模块,可提高细胞信号通路的效率和灵活性,从而协调复杂的反应。在这些蛋白质中,Grb2(生长因子受体结合蛋白2)因其独特的“三明治”结构而成为关键调节因子。尽管缺乏内在酶活性,但最近的研究表明,Grb2不仅作为一个被动桥梁,还利用分子内变构通讯来调节结合特异性。在本研究中,我们比较了Grb2的SH2-SH3与Gab2的动力学结合特性,并使用两种模拟SH2生理配体的不同肽对SH2结构域的结合状态进行了相同实验。我们的结果表明,SH2结构域起着关键的调节作用,在游离态和结合态表现出明显不同的行为,且取决于它所结合的配体。这表明结构域内变构如何调节选择性。测量靶蛋白激活水平的体外功能实验进一步支持了我们的假设。